Vesikari, Timo <br/><br/>
Sustained efficacy of the pentavalent rotavirus vaccine, RV5, up to 3.1 years following the last dose of vaccine.  [electronic resource] 

 -  The Pediatric infectious disease journal  Oct 2010 
 - 957-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-0987 
<br/><br/><label>Standard No.: </label>10.1097/INF.0b013e3181e28e6e  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Female<br/>Finland--epidemiology<br/>Follow-Up Studies<br/>Hospitalization--statistics & numerical data<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Male<br/>Rotavirus Infections--epidemiology<br/>Rotavirus Vaccines--immunology<br/>Time Factors<br/>Vaccines, Attenuated--immunology